Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $103.53 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $25.90 | 1 | $0 (2022) |
| Genmab U.S., Inc. | $23.29 | 1 | $0 (2022) |
| Lilly USA, LLC | $18.73 | 1 | $0 (2024) |
| EISAI INC. | $18.31 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $17.30 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.73 | 1 | Lilly USA, LLC ($18.73) |
| 2022 | $84.80 | 4 | GlaxoSmithKline, LLC. ($25.90) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 11/16/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: ONCOLOGY | ||||||
| 11/10/2022 | Genmab U.S., Inc. | TIVDAK (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: ONCOLOGY | ||||||
| 08/11/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: Oncology | ||||||
About Brandy Standard
Brandy Standard is a Neonatal Intensive Care healthcare provider based in Brighton, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2021. The National Provider Identifier (NPI) number assigned to this provider is 1962168419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brandy Standard has received a total of $103.53 in payments from pharmaceutical and medical device companies, with $18.73 received in 2024. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($103.53).
Practice Information
- Specialty Neonatal Intensive Care
- Other Specialties Family
- Location Brighton, CO
- Active Since 11/09/2021
- Last Updated 08/01/2025
- Taxonomy Code 163WN0002X
- Entity Type Individual
- NPI Number 1962168419
Products in Payments
- ZEJULA (Drug) $25.90
- TIVDAK (Drug) $23.29
- MOUNJARO (Drug) $18.73
- Lenvima (Drug) $18.31
- KEYTRUDA (Biological) $17.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.